GenVec (GNVC) Reports In-Line Q1 Loss of $0.06
More News related to GNVC
- GenVec (GNVC) Reports In-line Results for Q3
- GenVec Reports Third Quarter 2009 Financial Results
- SAIC-Frederick Signs $22M Contract with GenVec (GNVC) for Flu and HIV Vaccine Development
- GenVec Signs New Contract to Support HIV and Influenza Vaccine Development
- Trading Radar for 11/05: Starbucks (SBUX), CBS Corp. (CBS), CVS (CVS), Toyota (TM), Thomson Reuters (TRI)
More News related to Earnings
- ManTech (MANT) awarded a $286.5 million contract from the U.S. Army
- Starbucks' (SBUX) Schultz Says Via Exceeding Expectations, Company Done Closing Stores
- Highlights From DIVX's Q3 Conference Call; Licensing Business Transitioning to New Growth Categories; Guides Above for Q4 EPS
- Ambac (ABK) Slammed as 10-Q Warns of Possible Bankruptcy Protection
- Globecomm Systems (GCOM) Awarded $17.7 Million Contract
GenVec, Inc. (Nasdaq: GNVC) reports Q1 loss of $0.06, in-line with the analyst estimate of ($0.06). Revenue for the quarter was $3.8 million, versus the consensus of $3.40 million.
Related Categories
EarningsStocks Mentioned
-0.03Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
